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Abstract
Bone marrow (BM)-derived stem/progenitor cells play an important role in ischemia-induced angiogenesis in cardiovascular
diseases. Heat shock factor 1 (HSF1) is known to be induced in response to hypoxia and ischemia. We examined whether
HSF1 contributes to ischemia-induced angiogenesis through the mobilization and recruitment of BM-derived stem/
progenitor cells using HSF1-knockout (KO) mice. After the induction of ischemia, blood flow and microvessel density in the
ischemic hindlimb were significantly lower in the HSF1-KO mice than in the wild-type (WT) mice. The mobilization of BM-
derived Sca-1- and c-kit-positive cells in peripheral blood after ischemia was significantly lower in the HSF1-KO mice than in
the WT mice. BM stem/progenitor cells from HSF1-KO mice showed a significant decrease in their recruitment to ischemic
tissue and in migration, adhesion, and survival when compared with WT mice. Blood flow recovery in the ischemic hindlimb
significantly decreased in WT mice receiving BM reconstitution with donor cells from HSF1-KO mice. Conversely, blood flow
recovery in the ischemic hindlimb significantly increased in HSF1-KO mice receiving BM reconstitution with donor cells from
WT mice. These findings suggest that HSF1 contributes to ischemia-induced angiogenesis by regulating the mobilization
and recruitment of BM-derived stem/progenitor cells.
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Introduction
Angiogenesis in response to ischemia, including the sprouting of
new capillary branches from pre-existing vessels, is an adaptive
response in tissues with compromised blood supply, and it is
important for perfusion after critical ischemia [1,2,3]. Recent
evidence suggests that neovascularization within ischemic tissue
involves the participation of bone marrow (BM)-derived stem/
progenitor cells. The stem/progenitor cells in BM are mobilized
into the peripheral blood in response to ischemia and are then
recruited to the sites of ischemic injury to contribute to
neovascularization, promoting blood flow recovery [4,5,6,7].
Therefore, the mobilization and recruitment of BM-derived
stem/progenitor cells are critical in ischemia-induced neovascu-
larization. However, the exact cellular and molecular mechanisms
regulating the mobilization and recruitment of these cells are fully
not understood.
Heat shock factor 1 (HSF1) is an essential transcription factor in
the response to cellular stress including a wide range of acute and
chronic perturbation of pathophysiological states, and regulates
the expression of heat shock proteins (HSPs) and numerous other
molecules [8,9,10,11]. HSF1 is also known to be induced and/or
activated in response to hypoxia and ischemia [12]. However, the
role of HSF1 in ischemia-induced angiogenesis remains unclear.
Recent studies have shown that HSP90 or heme oxygenase-1
(HSP32), one of the target molecules of HSF1, may contribute to
neovascularization after hindlimb ischemia [13,14,15]. Interest-
ingly, it has been reported that heme oxygenase-1 is required for
the mobilization of BM progenitor cells [15,16]. Given that the
expression of HSPs is mainly regulated by HSF1, it is possible that
HSF1 regulates the mobilization and recruitment of BM-derived
stem/progenitor and contributes, at least in part, to angiogenesis
in response to ischemia.
In this study, we addressed the role of HSF1 in ischemia-
induced angiogenesis. Using HSF1-knockout (KO) mice, we
investigated the angiogenic response (blood flow recovery and
microvessel density) and the mobilization and recruitment of BM-
derived stem/progenitor cells after hindlimb ischemia.
Materials and Methods
Animals
The generation of HSF1-knockout (KO) mice on an ICR
background has been described previously [17,18,19]. Wild-type
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All mice used for these experiments were males aged 12 to 18
weeks. All animal procedures were approved by the Institutional
Animal Care and Use Committee of Yamaguchi University and
conformed to the Guide for the Care and Use of Laboratory
Animals published by the US National Institutes of Health (NIH
Publication No. 85-23, revised 1996).
Ischemic hindlimb model
The mouse ischemic hindlimb model was created as described
previously [20,21,22]. After mice were administered general
anesthesia, the left femoral artery was exposed and ligated, and
its branches were dissected free and excised.
Measurement of blood flow in ischemic hindlimbs
Blood flow in the ischemic hindlimb was measured using a laser
Doppler perfusion imaging system (PeriScan System, Perimed AB,
Stockholm, Sweden), as described previously [20,21,22]. The
recovery of perfusion in the ischemic hindlimb of each mouse was
estimated by the percentage of limb blood flow, which was
calculated by the average perfusion of the left hindlimb compared
to that of the normal right hindlimb.
Histological analysis of microvessel density
Mice were euthanized 21 days after induction of ischemia, and
the quadriceps and adductor muscles were harvested and
embedded in OCT compound (Sakura Finetechnical, Tokyo,
Japan). To detect the development of microvessels in the ischemic
muscles, frozen sections (5 mm) were stained for alkaline phospha-
tase using an indoxyl tetrazolium method, as described previously
[20,21]. A total of 15 different fields (6200-fold magnification) of
three independent slides from different cross-sections were
randomly selected for each mouse, and the number of microvessels
and muscle fibers was counted. The density of microvessels was
expressed as the microvessels/muscle fiber ratio.
Measurement of angiogenic factors in plasma and limb
muscle tissue
Plasma was obtained from the peripheral blood of mice both
prior to and 3 days after limb ischemia. Tissue samples from
ischemic and non-ischemic limbs were collected 3 days after
ischemia. Protein extracts from the tissue samples were prepared
by homogenization in a buffer containing 50 mM Tris-HCl,
pH 7.2, 100 mM NaCl, 1% NP-40, and complete protease
inhibitor mixture tablets (Roche, Mannheim, Germany). The
concentration of vascular endothelial growth factor (VEGF) and
stromal cell-derived factor-1 (SDF-1) in the plasma and limb tissue
was determined using a commercially available ELISA kit (R & D
Systems, Minneapolis, MN, USA) in accordance with the
manufacturer’s instructions.
Analysis of mobilization of BM-derived stem/progenitor
cells
To monitor the mobilization of BM-derived stem/progenitor
cells, we collected peripheral blood both prior to and 3 days after
limb ischemia. After density gradient centrifugation, peripheral
blood mononuclear cells were stained with phycoerythrin (PE)-
conjugated rat anti-mouse Sca-1 antibody (eBioscience Inc., San
Diego, CA, USA) or c-kit antibody (eBioscience Inc.). Respective
isotypes (eBioscience Inc.) were used as a negative control.
Quantitative flow cytometric analysis was performed using a
fluorescence-activated cell sorter (FACSCalibur; BD Biosciences,
Franklin Lakes, NJ, USA). We analyzed the acquired data using
CellQuest Pro software (BD Biosciences).
Isolation of BM cells
BM was collected from the femur and tibia, and BM
mononuclear cells were isolated by density gradient centrifugation,
as described previously [20]. Isolated BM cells were used for
subsequent analysis.
Analysis of the amount of stem/progenitor cells in BM
cells
To examine the amount of stem/progenitor cells in BM cells,
Sca-1- and c-kit-positive cells in freshly isolated BM cells from WT
or HSF1-KO mice were measured by flow cytometry, as described
above.
Assessment of recruitment of BM cells into limb tissue
To investigate the capacity for recruitment of BM cells into
ischemic tissue, isolated BM cells from WT or HSF1-KO mice
were labeled with intracellular fluorescent dye of carboxyfluor-
escein diacetate succinimidyl ester (CFSE, Molecular Probes, Inc.,
Eugene, OR, USA) as described previously [22]. The CFSE-
labeled BM cells (8610
6) were intravenously injected into WT
mice 1 day after induction of limb ischemia. Mice were euthanized
1 day after the injection of BM cells, and the muscles from the
ischemic hindlimbs were harvested. Frozen sections were used to
evaluate the recruitment in ischemic tissue by direct vision of
CFSE-positive cells under a fluorescence microscope (6200-fold
magnification). Nuclei were stained with 49,6-diamidine-29-
phenylindole (DAPI). A total of 15 different fields from three
independent slides for different cross-sections were randomly
selected for each mouse, and the number of CFSE-positive cells
was counted. The results are expressed as the number of CFSE-
positive cells/field.
Migration assay
Cell migration was determined by a modified Boyden chamber
assay [23]. Briefly, isolated BM cells (2610
5) were suspended in
100 ml of serum-free RPMI 1640 containing 0.05% bovine serum
albumin (BSA) and were added to the upper chamber (Trans-
membrane, 8 mm pore size, Corning Incorporated, Corning, NY,
USA). The lower chamber of the apparatus was filled with 600 ml
of serum-free RPMI 1640 containing 0.05% BSA without or with
recombinant mouse SDF-1 (100 ng/ml, R&D systems). The whole
apparatus was incubated at 37uC for 6 hours. The number of cells
migrating to the lower chamber was counted in four random
microscopic fields (6200-fold magnification). Data are expressed
as the number of migrated cells/field.
Adhesion assay
The cell adhesion assay was performed as described previously
[22]. Isolated BM cells suspended in RPMI 1640 containing 10%
FBS were seeded on fibronectin-coated 24-well plates (1610
6/ml/
well) and incubated at 37uCi n5 %C O 2. After 1 day of culture,
non-adherent cells were removed by tapping and gently washing
the wells three times with PBS. The number of adherent cells was
counted in five random microscopic fields (6200-fold magnifica-
tion) in each well. Data are expressed as the number of adherent
cells/field.
Survival analysis
Cell viability was determined by trypan blue dye exclusion, as
described previously [20,21]. Isolated BM cells suspended in
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culture plates (2610
5/200 ml/well) and were then incubated at
37uCi n5 %C O 2. After 1 day of culture, the cell survival rate was
calculated as the percentage of surviving cells among all of the
seeded cells.
BM reconstitution and blood flow recovery of ischemic
limbs
To assess the contribution of BM-derived cells to ischemia-
induced angiogenesis, BM transplantation (BMT) was performed,
as previously described [24]. Briefly, WT or HSF1-KO mice were
subjected to lethal irradiation (10 Gy) and were then implanted
intravenously with 8610
6 BM cells that had been isolated from
WT or HSF1-KO mice. We made the following 4 groups of
chimeric mice: recipient WT mice implanted with donor BM cells
from WT mice; recipient WT mice implanted with donor BM cells
from HSF1-KO mice; recipient HSF1-KO mice implanted with
donor BM cells from WT mice; and recipient HSF1-KO mice
implanted with donor BM cells from HSF1-KO mice.
The ischemic hindlimb model was implemented in these
chimera mice 8 weeks after BMT, and blood flow in the ischemic
hindlimb was measured using a laser Doppler perfusion imaging
system (PeriScan System) 14 days after ischemia, as described
above.
Analysis of HSF1 expression in limb tissue and BM cells
after ischemia
To examine the expression of HSF1 in limb tissues and BM cells
in WT mice after hindlimb ischemia, we performed western blot
analysis, as described previously [22,25] . Tissue samples from
ischemic and non-ischemic limbs were collected 3 days after
ischemia, and protein extracts were prepared as described above.
BM cells were collected both prior to and 3 days after hindlimb
ischemia, and lysed in a buffer containing 20 mM Tris-HCl,
pH 7.5, 150 mM NaCl, 1% Triton X-100, and complete protease
inhibitor mixture tablets (Roche). Equal amount of protein from
tissue samples or cell lysates was subjected to sodium dodecyl
sulfate-polyacrylamide gel electrophoresis, and transferred onto a
polyvinylidene difluoride membrane (Millipore, Bedford, MA,
USA). The blotted membranes were incubated with primary
antibodies to HSF1 (10H8; Enzo Life Science, Inc., Farmingdale,
NY, USA) or b-actin (Sigma, St. Louis, MO, USA), as an internal
control. Corresponding horseradish peroxidase-conjugated anti-
bodies were used as the second antibody. Signals were visualized
with an enhanced chemiluminescence Western blot detection
system (GE Healthcare UK Ltd, Buckinghamshire, United
Kingdom) and recorded with luminescent image analyzer (LAS-
1000; Fuji Film Co., Tokyo, Japan). Each band was quantified
using Image J software, and level of HSF1 was normalized to those
of b-actin. Data are expressed as the fold increase.
Statistical analysis
All data are expressed as the mean 6 SD. Differences between
mean values of multiple groups were evaluated using ANOVA
followed by Scheffe’s procedure. Comparisons between two
groups were made using unpaired Student’s t-tests. A value of
P,0.05 was considered significant. All analyses were performed
with StatView software (Version 5.0).
Results
Impaired ischemia-induced angiogenesis in HSF1-KO
mice
We examined the angiogenic response in ischemic limbs in the
HSF1-KO mice. We took serial measurements of the perfusion of
the ischemic hindlimbs prior to, and 3, 7, 14, and 21 days after
ischemia. Laser Doppler perfusion imaging showed profound
differences in blood flow in the ischemic hindlimbs between HSF1-
KO and WT mice at 21 days (Figure 1A). Quantitative analysis
also showed that the percentage of limb blood flow was
significantly lower in the HSF1-KO mice than in WT mice
(P,0.001) (Figure 1B). To detect microvessels in the ischemic
muscles, staining for alkaline phosphatase was performed 21 days
after ischemia. Histological analysis revealed that microvessel
density was significantly lower in the HSF1-KO mice than in WT
mice (P,0.001) (Figure 1C and 1D). All of these findings indicate
that the HSF1-KO mice showed an impaired angiogenic response
in the ischemic limbs.
VEGF and SDF-1 levels in plasma and limb tissue of HSF1-
KO mice
To investigate the reason for the impaired angiogenesis in the
HSF1-KO mice, we examined how the levels of VEGF and SDF-
1, two well-known critical factors regulating angiogenesis
[26,27,28,29], in the plasma and limb tissue, differed between
KO and WT mice in response to ischemia. We found that the
VEGF levels in the plasma and limb tissue in the HSF1-KO mice
increased after inducing limb ischemia (Figure 2A and 2B), and
that VEGF levels in the plasma and ischemic tissue did not
significantly differ between HSF1-KO and WT mice 3 days after
ischemia. We also observed increased levels of SDF-1 in the
plasma and limb tissue in the HSF1-KO mice after ischemia,
which was similar to WT mice (Figure 2C and 2D). These results
suggest that impaired angiogenesis in the HSF1-KO mice likely
did not result from decreased levels of VEGF and SDF-1.
Decreased mobilization of BM-derived stem/progenitor
cells in HSF1-KO mice
To evaluate the mobilization of BM stem/progenitor cells, we
examined the mobilized these cells in response to ischemia. Flow
cytometric analysis showed that the Sca-1- and c-kit-positive cells
in the peripheral blood significantly increased in the WT mice but
not in the HSF1-KO mice 3 days after ischemia (Figure 3A and
3B). Sca-1- and c-kit-positive cells in the peripheral blood before
ischemia did not significantly differ between WT and HSF1-KO
mice. Furthermore, there was no significant difference in the total
amount (Figure 3C) or the amount of cells positive for Sca-1
(Figure 3D) and c-kit (Figure 3E) between BM cells from WT and
HSF1-KO mice. These results indicate a decreased mobilization
of BM-derived stem/progenitor cells in the HSF1-KO mice,
although the amount of stem/progenitor cells in BM cells did not
differ between WT and HSF1-KO mice.
Impaired recruitment of BM cells from HSF1-KO mice to
ischemic tissue
We next examined the capacity for recruitment of BM cells
from WT or HSF1-KO mice to ischemic tissues of WT mice.
Despite the intravenous injection of the same number of CFSE-
labeled BM cells, the accumulation of BM cells from the HSF1-
KO mice was remarkably lower in the ischemic tissue than in
those from the WT mice (Figure 4A). Quantitative analysis showed
that the number of CFSE-labeled cells in the ischemic tissue was
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in those from the WT mice (P,0.01) (Figure 4B). These data
suggest that the recruitment of BM cells to the ischemic tissue was
impaired in the HSF1-KO mice.
Functional impairment of BM cells from HSF1-KO mice
In addition, we performed an in vitro assessment of BM cell
function, including migration, adhesion, and survival, because
these functions are important for the in vivo mobilization and
Figure 1. Angiogenic response in ischemic limbs. (A) Representative color-coded images representing blood flow distribution. Arrows indicate
the ischemic hindlimbs. (B) Quantitative analysis of the time course of recovery of blood flow in ischemic limbs. (C) Representative images of
microvessels stained for alkaline phosphatase. Bars indicate 100 mm. (D) Quantitative analysis of microvessel density. Quantitative analysis revealed
that the blood flow (B) and microvessel density (D) in the ischemic hindlimb significantly decreased in the HSF1-KO mice compared to the WT mice,
21 days after the induction of ischemia (n=5 or 6 animals/group).
doi:10.1371/journal.pone.0037934.g001
Figure 2. VEGF and SDF-1 levels in plasma and limb tissue. ELISA analysis showed that VEGF (A, B) and SDF-1 (C, D) levels in the plasma (A, C)
and ischemic limb tissue (B, D) increased in both HSF1-KO and WT mice, 3 days after ischemia (n=5–8 animals/group).
doi:10.1371/journal.pone.0037934.g002
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cells was significantly lower in the HSF1-KO mice than in the WT
mice, in both absence and presence of SDF-1 (P,0.05 and
P,0.001, respectively) (Figure 5A). The number of adherent cells
significantly decreased in the HSF1-KO mice than in the WT
mice (P,0.001) (Figure 5B). The survival rate was significantly
lower in the HSF1-KO mice than in the WT mice (P,0.001)
(Figure 5C). These results suggest that a deficiency of HSF1
contributes to the impairment of the function of BM cells in
survival, adhesion, and movement.
Blood flow recovery in ischemic limbs after BMT
To further confirm our hypothesis that HSF1 contributes to
ischemia-induced angiogenesis by regulating the mobilization and
recruitment of BM-derived cells, we induced hindlimb ischemia in
the chimeric mice after mismatched BMT. The recovery of blood
flow in the ischemic hindlimb significantly decreased in recipient
WT mice receiving BM reconstitution with donor BM cells from
HSF1-KO mice (P,0.001). Conversely, the blood flow in the
ischemic hindlimb significantly increased in recipient HSF1-KO
mice receiving BM reconstitution with donor BM cells from WT
mice (P,0.01), but it was not as much as that of the recipient WT
mice receiving BM reconstitution with donor BM cells from WT
mice (P,0.001) (Figure 6). All of these findings suggest that, in the
HSF1-KO mice, impaired neovascularization in response to
ischemia might be attributable, at least in part, to the dysfunction
of BM cells.
Increased expression of HSF1 in ischemic limb tissues
and BM cells after ischemia
We investigated the change in the expression of HSF1 protein in
limb tissues and BM cells in WT mice after limb ischemia.
Western blot analysis showed that the expression of HSF1 was
significantly higher in the ischemic limb tissue than in the non-
ischemic limb tissue (P,0.05) (Figure 7A and 7B). Moreover,
HSF1 expression was also significantly increased in the BM cells
from mice with the induction of limb ischemia when compared to
the BM cells from healthy mice (P,0.05) (Figure 7C and 7D).
These results suggest that the induction of limb ischemia can
induce the expression of HSF1 in the local ischemic limb tissue
and BM cells.
Discussion
The novel finding of this study is that a deficiency in HSF1
results in an impairment in neovascularization after ischemia. Our
study provides the first evidence that HSF1 plays a pivotal role in
ischemia-induced neovascularization by regulating the mobiliza-
tion and recruitment of BM-derived stem/progenitor cells.
We found that HSF1-KO mice have impaired ischemia-
induced neovascularization, as shown by the lower microvessel
density and blood flow in the ischemic limbs. To elucidate the
reason for the reduced angiogenic potential in the HSF1-KO
mice, we examined the VEGF and SDF-1 in the plasma and
ischemic tissue, as VEGF and SDF-1 are known to be induced by
ischemia/hypoxia and contribute to angiogenesis [26,27,28,29].
However, the fact that VEGF and SDF-1 levels in the plasma and
Figure 3. Mobilization of BM-derived cells in the peripheral blood. Flow cytometric analysis showed that the mobilization of BM-derived Sca-
1- (A) and c-kit-positive cells (B) in the peripheral blood significantly increased in the WT mice but not in the HSF1-KO mice, 3 days after ischemia
(n=4 animals/group). However, the total amount (C) or the subpopulation of Sca-1- (D) and c-kit-positive cells (E) in BM cells did not differ between
WT and HSF1-KO mice (n=3 animals/group).
doi:10.1371/journal.pone.0037934.g003
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induction of ischemia that was similar to the WT mice, indicated
that the impairment in angiogenic potential in the HSF1-KO mice
is likely not attributable to decreased levels of VEGF and SDF-1.
Figure 4. Recruitment of BM cells to ischemic limbs. (A) CFSE-
positive cells (green) recruited to the ischemic limbs were visualized
directly under a fluorescent microscope. Nuclei were stained with DAPI
(blue). Bars indicate 100 mm. (B) Quantitative analysis of CFSE-positive
cells showed a significant decrease in the recruitment of the BM cells
from KO mice, compared with those from WT mice (n=3 animals/
group).
doi:10.1371/journal.pone.0037934.g004
Figure 5. In vitro assessment of BM cell function. (A) Cell migration was determined by a Boyden chamber assay. (B) Cells were seeded on
fibronectin-coated plates, and the number of adherent cells was counted after 1 day of culture. (C) Cell viability was determined by trypan blue dye
exclusion after 1 day of culture. Quantitative analysis revealed that migration (A), adhesion (B), and survival (C) were all impaired in the BM cells from
KO mice, compared with those from WT mice (n=3 animals/group).
doi:10.1371/journal.pone.0037934.g005
Figure 6. Blood flow in ischemic limbs after BM reconstitution.
The blood flow of the ischemic hindlimbs of the chimeric mice after
mismatched BMT was measured by laser Doppler perfusion imaging.
The recovery of blood flow in the ischemic hindlimb significantly
decreased in recipient WT mice receiving BM reconstitution with donor
cells from KO mice. Conversely, the blood flow in the ischemic hindlimb
significantly improved in recipient KO mice receiving BM reconstitution
with donor cells from WT mice (n=5 animals/group).
doi:10.1371/journal.pone.0037934.g006
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recruited BM-derived cells in the ischemic limb, ischemia is also
known to induce the production of VEGF and SDF-1 from various
types of cells, including the endothelial cells and myoblasts.
Therefore, it was not surprising that these host cells, rather than
the recruited BM cells, might contribute to release the most
amount of VEGF within the limb tissue after the induction of
ischemia.
Next, we investigated the mobilization and recruitment of BM
stem/progenitor cells, as BM-derived stem/progenitor cells have
been shown to contribute to ischemia-induced neovascularization
[4,5,6,7]. The mobilization of BM-derived stem/progenitor cells
was blunted in HSF1-KO mice after the induction of ischemia,
and the recruitment of BM cells from HSF1-KO mice into
ischemic tissue also decreased. Furthermore, BM stem/progenitor
cells from HSF1-KO mice had decreased migration, adhesion,
and survival in vitro. Considering that the mobilization and
recruitment of BM-derived stem/progenitor cells are mediated
by migration, adhesion, and survival [5,6,7], it is likely that the
functional impairment of these cells is responsible for their
defective mobilization and recruitment. Taken together, we may
attribute the impaired neovascularization in the response to
ischemia in the HSF1-KO mice to the defective mobilization,
recruitment, and function of BM-derived stem/progenitor cells.
Indeed, we demonstrated that blood flow in the ischemic hindlimb
significantly decreased in WT mice receiving BM reconstitution
with cells from HSF1-KO mice.
It has been shown that the mobilization, recruitment, and
function in BM stem/progenitor cells are impaired in patients with
advanced age and systemic diseases, such as diabetes [5,30,31].
Therefore, it will be interesting for future studies to examine
whether the defective mobilization, recruitment, and function of
BM stem/progenitor cells in these patients are related to the
inactivation and decreased expression of HSF1.
Here, we have showed that the defective mobilization and
recruitment of BM-derived stem/progenitor cells are related to the
impairment of ischemia-induced angiogenesis. However, defective
mobilization and recruitment of these cells do not fully account for
the impaired neovascularization in the response to ischemia in
HSF1-KO mice, because the blood flow in the ischemic hindlimb
was lower in the HSF1-KO mice receiving WT BM reconstitution
than in the WT mice receiving WT BM reconstitution.
Considering that recent studies have revealed the contribution of
HSP90 or heme oxygenase-1 to neovascularization [13,14,15],
there is a possibility that changes in HSP expression within limb
tissue in response to ischemia may in part be associated with the
reduced angiogenic potential in the HSF1-KO mice. Interestingly,
we found the increased expression of HSF1 in the limb tissue after
ischemia. It keeps unclear how the enhanced HSF1 effects the
expression of HSPs, that are known to play a role of angiogenesis
in response to ischemia. Moreover, it remains to be seen whether
HSF1 affects the function of other types of cells, including
endothelial cells and myoblasts, for angiogenesis within the limb
tissue after the induction of ischemia. Further experiments are also
required to uncover whether HSF1 could contribute to the
engraftment efficiency of BMT. All of these will help us to
elucidate the additional roles of HSF1 in ischemia-induced
angiogenesis.
In conclusion, this study showed that ischemia-induced neovas-
cularization is impaired in HSF1 KO mice, which is likely related
to decreased mobilization and recruitment of BM-derived stem/
progenitor cells. Although further experiments are required to
examine in detail how HSF1 affects the number and function of
BM-derived stem/progenitor cells, HSF1 likely plays a role in
ischemia-induced angiogenesis by regulating the mobilization and
recruitment of BM stem/progenitor cells. HSF1 is expected to be a
new therapeutic target for the treatment of ischemic diseases.
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